FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claus Garbe

Research Profile

Disorders

Concepts & Ideas

Geographic Areas

Germany

Anatomy

Chemicals & Drugs

Procedures

Sentinel Lymph Node Biopsy

Co-author Network

Publications

TOP 3
Andrea Forschner; Vanessa Heinrich; Friedegund Meier; Annette Pflugfelder; Claus Garbe
The role of radiotherapy in the overall treatment of melanoma.
Laura Held; Ulrike Leiter; Jane L Messina; Gisela Metzler; Thomas K Eigentler; Claus Garbe; L Frank Glass; Jürgen Bauer
Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
Daniela Beck; Tilo Biedermann; Christian Busch; Stefan Drießen; Jürgen Eberle; Keith Flaherty; Claus Garbe; Juan Lucio Iovanna; Dagmar Kulms; Konstantinos G Lasithiotakis; Heike Niessner; Kim H T Paraiso; Dirk Schadendorf; Martin Schaller; Birgit Schittek; Tobias Sinnberg; Keiran S M Smalley; Björn Stork; Sophie Vasseur; Benjamin Weide; Sebastian Wesselborg; Jürgen Bauer; Friedegund Meier
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claus Garbe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrea Forschner; Vanessa Heinrich; Friedegund Meier; Annette Pflugfelder; Claus Garbe
The role of radiotherapy in the overall treatment of melanoma.
Clinics in dermatology 2013;31(3):282-9.
2013: Laura Held; Ulrike Leiter; Jane L Messina; Gisela Metzler; Thomas K Eigentler; Claus Garbe; L Frank Glass; Jürgen Bauer
Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
The American journal of pathology 2013;182(3):640-5.
2013: Daniela Beck; Tilo Biedermann; Christian Busch; Stefan Drießen; Jürgen Eberle; Keith Flaherty; Claus Garbe; Juan Lucio Iovanna; Dagmar Kulms; Konstantinos G Lasithiotakis; Heike Niessner; Kim H T Paraiso; Dirk Schadendorf; Martin Schaller; Birgit Schittek; Tobias Sinnberg; Keiran S M Smalley; Björn Stork; Sophie Vasseur; Benjamin Weide; Sebastian Wesselborg; Jürgen Bauer; Friedegund Meier
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.
Science signaling 2013;6(260):ra7.
2013: Benjamin Weide; Ulrike Leiter; Friedegund Meier; Annette Pflugfelder; Jürgen Bauer; Petra Büttner; Thomas K Eigentler; Christine Faller; Andrea Forschner; Claus Garbe
Prognostic Factors of Melanoma Patients with Satellite or In-Transit Metastasis at the Time of Stage III Diagnosis.
PloS one 2013;8(4):e63137.
2013: Laura Held; Ulrike Leiter; Thomas K Eigentler; Claus Garbe; Mark-Jürgen Berneburg
Effective combination of photodynamic therapy and imiquimod 5% cream in the treatment of actinic keratoses: three cases.
BioMed research international 2013;2013():102698.
2012: Eggert Stockfleth; Dorothea Terhorst; Christos C Zouboulis; Thomas Diepgen; Claus Garbe; Harald Gollnick; Axel Hauschild; Helmut Kerl; Christian Korting; Hans Merk; Claus Oster-Schmidt; Martin Schlaeger; Wolfram Sterry; Carola Berking
[In Process Citation].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2012;10 Suppl 7():S1-23.
2012: Sarah Schott; Claus Garbe; Julia Adams; Arno Bern; Christian Busch
Expression of oxytocin and its receptor in healthy and varicose great saphenous veins.
Pathology 2012;44(7):670-3.
2012: Laura Held; Ulrike Leiter; Jane Messina; Gisela Metzler; Juergen Bauer; Thomas K Eigentler; Jeannette Gogel; Claus Garbe
Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcome.
Journal of cutaneous pathology 2012;39(12):1088-93.
2012: Sarah Schott; Tobias Sinnberg; Sascha Venturelli; Jessie Villanueva; Claus Garbe; Kristian Ikenberg; Friedegund Meier; Heike Niessner; Alexander Berger; Christian Busch
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells.
International journal of cancer. Journal international du cancer 2012;131(9):2165-74.
2012: Claus Garbe
Ipilimumab with fotemustine in metastatic melanoma.
The lancet oncology 2012;13(9):851-2.
2012: Keith T Flaherty; Claus Garbe; Jessica C Hassel; Peter Hersey; James M G Larkin; Anne-Marie Martin; Mark R Middleton; Mohammed Milhem; Peter Mohr; Paul Nathan; Marta Nyakas; Daniele Ouellet; Kiran Patel; Caroline Robert; Piotr Rutkowski; Dirk Schadendorf; Laurie J Sherman; Uwe Trefzer; Jochen Utikal; Frank S Wu; Jürgen C Becker; Michelle Casey; Lev V Demidov; Brigitte Dreno; Reinhard Dummer
Improved survival with MEK inhibition in BRAF-mutated melanoma.
The New England journal of medicine 2012;367(2):107-14.
2012: Tarun Mehra; Gisela Metzler; Jürgen Bauer; Martin Köberle; Claus Garbe
Isotopic response of graft versus host disease following herpes zoster infection: case report and review of the literature.
Acta dermato-venereologica 2012;92(4):383-4.
2012: Benjamin Weide; Henning Zelba; Annette Pflugfelder; Dirk Schadendorf; Antje Sucker; Erik H J G Aarntzen; Petra Büttner; I Jolanda M De Vries; Evelyna Derhovanessian; Anna Maria Di Giacomo; Thomas K Eigentler; Claus Garbe; Michele Maio; Graham Pawelec
Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(15):1835-41.
2012: Julia Adams; Arno Bern; Claus Garbe; Kristian Ikenberg; Matthias Renz; Sarah Schott; Christian Busch
A novel role for relaxin-2 in the pathogenesis of primary varicosis.
PloS one 2012;7(6):e39021.
2012: Otmar Elsaesser; Helmut Breuninger; Petra G Buettner; Thomas K Eigentler; Ulrike Leiter; Friedegund Meier; Gisela Metzler; Benjamin Weide; Claus Garbe
Prognosis of sentinel node staged patients with primary cutaneous melanoma.
PloS one 2012;7(1):e29791.
2011: Giorgios Papaspyrou; Dirk Schadendorf; Jochen A Werner; Claus Garbe; Axel Hauschild; Friederike Egberts
Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
Melanoma research 2011;21(6):475-82.
2011: Alexandra Boehringer; Claus Garbe; Ulrike Leiter; Gisela Metzler; Matthias Moehrle; Helmut Breuninger
Extramammary Paget's disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2011;37(10):1417-26.
2011: Magdalena Feldhahn; Claus Garbe; Oliver Kohlbacher; Diana Meckbach; Moritz Menzel; Benjamin Weide; Peter Bauer; Jürgen Bauer
No evidence of viral genomes in whole-transcriptome sequencing of three melanoma metastases.
Experimental dermatology 2011;20(9):766-8.
2011: Claus Garbe; Markus Hantschke; Peter Kurschat; Heinz Kutzner; Dieter Metze; Jürgen Bauer; Norbert Blödorn-Schlicht; Thomas K Eigentler; Falko Fend; Harald Pressler; Michael Reusch; Martin Röcken; Rudolf Stadler; Michael Tronnier; Amir S Yazdi; Gisela Metzler
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2011;9(9):690-9.
2011: Laura Held; Marko Held; Friedegund Meier; Martin Röcken; Thomas K Eigentler; Claus Garbe; Jürgen Bauer
Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2011;9(7):510-6.
2011: Friederike Egberts; L Frey; Claus Garbe; R Gutzmer; J C Hassel; J C Becker; Carola Berking; A Degen; K C Kaehler; E Livingstone; C Mauch; Peter Mohr; Ted King; Dirk Schadendorf; F Schenck; U Trefzer; Selma Ugurel; Michael Weichenthal; T Wilhelm; Axel Hauschild
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(7):1667-74.
2011: Liljana Mervic; Ulrike Leiter; Friedegund Meier; Thomas K Eigentler; Andrea Forschner; Gisela Metzler; Igor Bartenjev; Petra Büttner; Claus Garbe
Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
Melanoma research 2011;21(3):244-52.
2011: Anne F Pfeil; Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Benjamin Weide; Friedegund Meier; Claus Garbe
Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.
Melanoma research 2011;21(3):228-34.
2011: Dieter Leupold; Matthias Scholz; Goran Stankovic; Julian Reda; Susanne Buder; Reinhold Eichhorn; Gert Wessler; Markus Stücker; Klaus Hoffmann; Jürgen Bauer; Claus Garbe
The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes.
Pigment cell & melanoma research 2011;24(3):438-45.
2011: Thomas K Eigentler; Adina Figl; Dietmar Krex; Peter Mohr; Cornelia Mauch; Knut Rass; Azize Bostroem; Oliver Heese; Oliver Koelbl; Claus Garbe; Dirk Schadendorf
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
Cancer 2011;117(8):1697-703.
2011: Benjamin Weide; Thomas K Eigentler; Annette Pflugfelder; Ulrike Leiter; Friedegund Meier; Jürgen Bauer; Diethard Schmidt; Peter Radny; Claudia Pföhler; Claus Garbe
Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up.
Cancer immunology, immunotherapy : CII 2011;60(4):487-93.
2011: Heike Niessner; Daniela Beck; Tobias Sinnberg; Konstantinos G Lasithiotakis; Evelyn Maczey; Jeannette Gogel; Sascha Venturelli; Alexander Berger; Mario Mauthe; Mahmoud Toulany; Keith Flaherty; Martin Schaller; Dirk Schadendorf; Tassula Proikas-Cezanne; Birgit Schittek; Claus Garbe; Dagmar Kulms; Friedegund Meier
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells.
The Journal of investigative dermatology 2011;131(2):468-79.
2011: Tobias Sinnberg; Michael Schwarz; Daniel Ewerth; Claus Garbe; Moritz Menzel; Birgit Sauer; Martin Schaller; Birgit Schittek
β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.
PloS one 2011;6(8):e23429.
2011: Lena Jakob; Gisela Metzler; Ko-Ming Chen; Claus Garbe
Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome.
PloS one 2011;6(4):e18397.
2011: Claus Garbe; Thomas K Eigentler; Ulrich Keilholz; Axel Hauschild; John M Kirkwood
Systematic review of medical treatment in melanoma: current status and future prospects.
The oncologist 2011;16(1):5-24.
2010: Tobias Sinnberg; Moritz Menzel; Susanne Kaesler; Tilo Biedermann; Birgit Sauer; Sven Nahnsen; Michael Schwarz; Claus Garbe; Birgit Schittek
Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis.
Cancer research 2010;70(17):6999-7009.
2010: Benjamin Weide; Evelyna Derhovanessian; Annette Pflugfelder; Thomas K Eigentler; Peter Radny; Henning Zelba; Claudia Pföhler; Graham Pawelec; Claus Garbe
High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma.
Cancer 2010;116(17):4139-46.
2010: V Lichte; B Dennenmoser; Klaus Dietz; Hans-Martin Häfner; Bettina Schlagenhauff; Claus Garbe; J Fischer; Matthias Moehrle
Professional risk for skin cancer development in male mountain guides--a cross-sectional study.
Journal of the European Academy of Dermatology and Venereology : JEADV 2010;24(7):797-804.
2010: Konstantinos G Lasithiotakis; Ioannis E Petrakis; Claus Garbe
Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment.
Melanoma research 2010;20(3):163-70.
2010: Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Andrea Forschner; Friedegund Meier; Claus Garbe
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
Melanoma research 2010;20(3):240-6.
2010: Stefanie Eichert; Matthias Möhrle; Helmut Breuninger; Martin Röcken; Claus Garbe; Jürgen Bauer
Diagnosis of cutaneous tumors with in vivo confocal laser scanning microscopy.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2010;8(6):400-10.
2010: Annette Pflugfelder; Benjamin Weide; Thomas K Eigentler; Andrea Forschner; Ulrike Leiter; Laura Held; Friedegund Meier; Claus Garbe
Incisional biopsy and melanoma prognosis: Facts and controversies.
Clinics in dermatology 2010;28(3):316-8.
2010: Ulrike Leiter; Thomas K Eigentler; Andrea Forschner; Annette Pflugfelder; Benjamin Weide; Laura Held; Friedegund Meier; Claus Garbe
Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.
Clinics in dermatology 2010;28(3):311-5.
2010: Andrea Forschner; Thomas K Eigentler; Annette Pflugfelder; Ulrike Leiter; Benjamin Weide; Laura Held; Friedegund Meier; Claus Garbe
Melanoma staging: facts and controversies.
Clinics in dermatology 2010;28(3):275-80.
2010: M Staudt; Konstantinos G Lasithiotakis; Ulrike Leiter; Friedegund Meier; Thomas K Eigentler; D D; Marcos Tatagiba; Peter Brossart; Claus Garbe
Determinants of survival in patients with brain metastases from cutaneous melanoma.
British journal of cancer 2010;102(8):1213-8.
2010: Ulrike Leiter; Claus Garbe
[Skin cancer in organ transplant patients. Epidemiology and management].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2010;61(3):207-13.
2010: Axel Hauschild; Michael Weichenthal; Ted King; Ruthild Linse; Carola Berking; Jörg Böttjer; Thomas Vogt; Konstanze Spieth; Thomas Eigentler; Norbert H Brockmeyer; Annette Stein; Helmut Näher; Dirk Schadendorf; Peter Mohr; Martin Kaatz; Michael Tronnier; Rüdiger Hein; Gerold Schuler; Friederike Egberts; Claus Garbe
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):841-6.
2010: Ulrike Leiter; Petra G Buettner; Katrin Bohnenberger; Thomas K Eigentler; Friedegund Meier; Matthias Moehrle; Helmut Breuninger; Claus Garbe
Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
Annals of surgical oncology 2010;17(1):129-37.
2009: Jürgen Bauer; E Kilic; J Vaarwater; Boris C Bastian; Claus Garbe; A de Klein
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma.
British journal of cancer 2009;101(5):813-5.
2009: Axel Hauschild; Michael Weichenthal; Ted King; Ruthild Linse; Jens Ulrich; Rudolf Stadler; Matthias Volkenandt; Stephan Grabbe; Ulrike Proske; Dirk Schadendorf; Norbert Brockmeyer; Thomas Vogt; Rainer Rompel; Roland Kaufmann; Martin Kaatz; Helmut Näher; Peter Mohr; Thomas Eigentler; Elisabeth Livingstone; Claus Garbe
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3496-502.
2009: Axel Hauschild; Sanjiv S Agarwala; Uwe Trefzer; David Hogg; Caroline Robert; Peter Hersey; Alexander Eggermont; Stephan Grabbe; Rene Gonzalez; Jens Gille; Christian Peschel; Dirk Schadendorf; Claus Garbe; Steven O'Day; Adil Daud; J Michael White; Chenghua Xia; Kiran Patel; John M Kirkwood; Ulrich Keilholz
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2823-30.
2009: Benjamin Weide; Steve Pascolo; Birgit Scheel; Evelyna Derhovanessian; Annette Pflugfelder; Thomas K Eigentler; Graham Pawelec; Ingmar Hoerr; Hans-Georg Rammensee; Claus Garbe
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(5):498-507.
2009: Tobias Sinnberg; Konstantinos G Lasithiotakis; Heike Niessner; Birgit Schittek; Keith T Flaherty; Dagmar Kulms; Evelyn Maczey; Minia Campos; Jeannette Gogel; Claus Garbe; Friedegund Meier
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.
The Journal of investigative dermatology 2009;129(6):1500-15.
2009: Friedegund Meier; emmanuella guenova; Stephan Clasen; Thomas K Eigentler; Andrea Forschner; Ulrike Leiter; Christina Zielinski; Björn Knaudt; Claus Garbe; Mark Berneburg
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.
Journal of the American Academy of Dermatology 2009;60(5):863-8.
2009: Christian Busch; Petra Bareiß; Tobias Sinnberg; Lothar Just; Manfred Wehrmann; Jörg Fuchs; Claus Garbe; Ulrich Drews
Isolation of three stem cell lines from human sacrococcygeal teratomas.
The Journal of pathology 2009;217(4):589-96.
2009: Corinna Simone Brod; Claus Garbe; Jan Schleicher; Martin Röcken; Melany Schilling
Acquired haemophilia mimicking dermatitis artefacta.
Acta dermato-venereologica 2009;89(2):194-5.
2008: Thomas K Eigentler; Peter Radny; Axel Hauschild; Ralf Gutzmer; Ruthild Linse; Claudia Pföhler; Stephan N Wagner; Dirk Schadendorf; Ulf Ellwanger; Claus Garbe
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
Melanoma research 2008;18(5):353-8.
2008: Matthias Oppitz; Christian Busch; Claus Garbe; Ulrich Drews
Distribution of muscarinic receptor subtype M3 in melanomas and their metastases.
Journal of cutaneous pathology 2008;35(9):809-15.
2008: Axel Hauschild; Uwe Trefzer; Claus Garbe; Katharina C Kaehler; Selma Ugurel; Felix Kiecker; Thomas Eigentler; Heiko Krissel; Astrid Schott; Dirk Schadendorf
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
Melanoma research 2008;18(4):274-8.
2008: Konstantinos G Lasithiotakis; Tobias W Sinnberg; Birgit Schittek; Keith T Flaherty; Dagmar Kulms; Evelyn Maczey; Claus Garbe; Friedegund Meier
Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.
The Journal of investigative dermatology 2008;128(8):2013-23.
2008: Claus Garbe; Peter Radny; R Linse; R Dummer; Ralf Gutzmer; J Ulrich; R Stadler; Michael Weichenthal; Thomas K Eigentler; Ulf Ellwanger; Axel Hauschild
Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1195-201.
2008: Claus Garbe; Dirk Schadendorf; Wilhelm Stolz; Matthias Volkenandt; Uwe Reinhold; Rolf-Dieter Kortmann; Christoph Kettelhack; Bernhard Frerich; Ulrich Keilholz; Reinhard Dummer; Günther Sebastian; Wolfgang Tilgen; Gerold Schuler; Andreas Mackensen; Roland Kaufmann; Axel Hauschild
Short German guidelines: malignant melanoma.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6 Suppl 1():S9-S14.
2008: Konstantinos G Lasithiotakis; Ulrike Leiter; Friedegund Meier; Thomas K Eigentler; Gisela Metzler; Matthias Moehrle; Helmut Breuninger; Claus Garbe
Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Cancer 2008;112(8):1795-804.
2008: Silke S Schwager; Ulrike Leiter; Petra G Buettner; Christiane Voit; Wolfgang Marsch; Ralf Gutzmer; Helmut Näher; Harald Gollnick; Eva Bettina Bröcker; Claus Garbe
Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Melanoma research 2008;18(2):112-9.
2008: Benjamin Weide; Jean-Philippe Carralot; Anne Reese; Birgit Scheel; Thomas Kurt Eigentler; Ingmar Hoerr; Hans-Georg Rammensee; Claus Garbe; Steve Pascolo
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(2):180-8.
2008: Christian Busch; Ulrich Drews; Stefan R Eisele; Claus Garbe; Matthias Oppitz
Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo.
International journal of cancer. Journal international du cancer 2008;122(3):526-33.
2008: Benjamin Weide; Claus Garbe; Hans-Georg Rammensee; Steve Pascolo
Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
Immunology letters 2008;115(1):33-42.
2008: Ulrike Leiter; Claus Garbe
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.
Advances in experimental medicine and biology 2008;624():89-103.
2007: Christian Busch; Ulrich Drews; Claus Garbe; Stefan R Eisele; Matthias Oppitz
Neural crest cell migration of mouse B16-F1 melanoma cells transplanted into the chick embryo is inhibited by the BMP-antagonist noggin.
International journal of oncology 2007;31(6):1367-78.
2007: Thomas K Eigentler; Anne Kamin; Benjamin Weide; Helmut Breuninger; Ulrich M Caroli; Matthias Möhrle; Peter Radny; Claus Garbe
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
Journal of the American Academy of Dermatology 2007;57(4):616-21.
2007: Friedegund Meier; S Busch; Konstantinos G Lasithiotakis; D Kulms; Claus Garbe; Evelyn Maczey; Meenhard Herlyn; Birgit Schittek
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment.
The British journal of dermatology 2007;156(6):1204-13.
2007: Birgit Schittek; Karin Psenner; Birgit Sauer; Friedegund Meier; Thomas Iftner; Claus Garbe
The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
International journal of cancer. Journal international du cancer 2007;120(10):2110-8.
2007: Claus Garbe; Thomas K Eigentler
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
Melanoma research 2007;17(2):117-27.
2007: Konstantinos G Lasithiotakis; Ulrike Leiter; Thomas K Eigentler; Helmut Breuninger; Gisela Metzler; Friedegund Meier; Claus Garbe
Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?
Cancer 2007;109(6):1174-82.
2007: Christina Pfannenberg; Philip Aschoff; Sandra Schanz; Susanne Martina Eschmann; Christian Plathow; Thomas K Eigentler; Claus Garbe; Klaus Brechtel; Reinhard Vonthein; Roland Bares; Claus D Claussen; Heinz-Peter Schlemmer
Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
European journal of cancer (Oxford, England : 1990) 2007;43(3):557-64.
2006: B Hoersch; Ulrike Leiter; Claus Garbe
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
The British journal of dermatology 2006;155(4):771-7.
2006: Konstantinos G Lasithiotakis; Ulrike Leiter; Roman Gorkievicz; Thomas K Eigentler; Helmut Breuninger; Gisela Metzler; Waltraud Strobel; Claus Garbe
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Cancer 2006;107(6):1331-9.
2006: Jürgen Bauer; Bernd Leinweber; Gisela Metzler; Andreas Blum; Rainer Hofmann-Wellenhof; N Leitz; K Dietz; Hans Peter Soyer; Claus Garbe
Correlation with digital dermoscopic images can help dermatopathologists to diagnose equivocal skin tumours.
The British journal of dermatology 2006;155(3):546-51.
2006: Beverly Raasch; Petra G Buettner; Claus Garbe
Basal cell carcinoma: histological classification and body-site distribution.
The British journal of dermatology 2006;155(2):401-7.
2006: Heiko Steffen; Siegbert Rieg; Imke Wiedemann; Hubert Kalbacher; Martin Deeg; Hans-Georg Sahl; Andreas Peschel; Friedrich Götz; Claus Garbe; Birgit Schittek
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge.
Antimicrobial agents and chemotherapy 2006;50(8):2608-20.
2006: Friedegund Meier; Silke Busch; Daniela Gast; Anne Göppert; Peter Altevogt; Evelyn Maczey; Svenja Riedle; Claus Garbe; Birgit Schittek
The adhesion molecule L1 (CD171) promotes melanoma progression.
International journal of cancer. Journal international du cancer 2006;119(3):549-55.
2006: Konstantinos G Lasithiotakis; U Leiter; Sabine Krüger-Krasagakis; Androniki Tosca; Claus Garbe
Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
The British journal of dermatology 2006;154(6):1123-7.
2006: Daniel Baechle; Thomas Flad; Alexander Cansier; Heiko Steffen; Birgit Schittek; Jonathan Tolson; Timo Herrmann; Hassan Dihazi; Alexander Beck; Gerhard A Mueller; Margret Mueller; Stefan Stevanovic; Claus Garbe; Claudia Mueller; Hubert Kalbacher
Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L.
The Journal of biological chemistry 2006;281(9):5406-15.
2006: Matthias Moehrle; K Dietz; Claus Garbe; Helmut Breuninger
Conventional histology vs. three-dimensional histology in lentigo maligna melanoma.
The British journal of dermatology 2006;154(3):453-9.
2006: V Jahn; Helmut Breuninger; Claus Garbe; Matthias Moehrle
Melanoma of the ear: prognostic factors and surgical strategies.
The British journal of dermatology 2006;154(2):310-8.
2006: Siegbert Rieg; Silke Seeber; Heiko Steffen; Andreas Humeny; Hubert Kalbacher; Stefan Stevanovic; Akihiko Kimura; Claus Garbe; Birgit Schittek
Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites.
The Journal of investigative dermatology 2006;126(2):354-65.
2006: Christian Müller-Horvat; Peter Radny; Thomas K Eigentler; Jürgen Schäfer; Christina Pfannenberg; Marius Horger; Sascha Khorchidi; Thomas Nägele; Claus Garbe; Claus D Claussen; Heinz-Peter Schlemmer
Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
European journal of cancer (Oxford, England : 1990) 2006;42(3):342-50.
2006: Thomas K Eigentler; Claus Garbe
Malignant melanoma: classification and staging of malignant melanoma.
Frontiers of radiation therapy and oncology 2006;39():149-58.
2005: Claus Garbe
Cutaneous melanoma: baseline and ongoing laboratory evaluation.
Dermatologic therapy 2005;18(6):413-21.
2005: Jürgen Bauer; Petra Büttner; Tine Sander Wiecker; Heike Luther; Claus Garbe
Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior.
International journal of cancer. Journal international du cancer 2005;116(5):755-61.
2005: Jean-Philippe Carralot; Benjamin Weide; Oliver Schoor; Jochen Probst; Birgit Scheel; Regina Teufel; Ingmar Hoerr; Claus Garbe; Hans-Georg Rammensee; Steve Pascolo
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.
Genetic vaccines and therapy 2005;3():6.
2005: Thomas K Eigentler; Peter Radny; Anne Kamin; Benjamin Weide; Ulrich M Caroli; Claus Garbe
[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2005;3(8):592-8.
2005: Siegbert Rieg; Heiko Steffen; Silke Seeber; Andreas Humeny; Hubert Kalbacher; Klaus Dietz; Claus Garbe; Birgit Schittek
Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(12):8003-10.
2005: Jürgen Bauer; Petra Büttner; Tine Sander Wiecker; Heike Luther; Claus Garbe
Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1,232 young German children.
International journal of cancer. Journal international du cancer 2005;115(1):121-6.
2005: Jürgen Bauer; Petra Büttner; Tine Sander Wiecker; Heike Luther; Claus Garbe
Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care.
American journal of epidemiology 2005;161(7):620-7.
2005: Anne Kamin; Thomas K Eigentler; Peter Radny; Jürgen Bauer; Benjamin Weide; Claus Garbe
Imiquimod in the treatment of extensive recurrent lentigo maligna.
Journal of the American Academy of Dermatology 2005;52(2 Suppl 1):51-2.
2005: Petra G Buettner; Ulrike Leiter; Thomas K Eigentler; Claus Garbe
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Cancer 2005;103(3):616-24.
2005: Friedegund Meier; Birgit Schittek; Silke Busch; Claus Garbe; Keiran Smalley; Kapaettu Satyamoorthy; Gang Li; Meenhard Herlyn
The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma.
Frontiers in bioscience : a journal and virtual library 2005;10():2986-3001.
2005: Jürgen Bauer; Andreas Blum; U Strohhäcker; Claus Garbe
Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
The British journal of dermatology 2005;152(1):87-92.
2004: Andreas Blum; H Luedtke; Ulf Ellwanger; R Schwabe; Gernot Rassner; Claus Garbe
Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions.
The British journal of dermatology 2004;151(5):1029-38.
2004: Thomas K Eigentler; Petra G Buettner; Ulrike Leiter; Claus Garbe
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4376-83.
2004: Andreas Blum; Rainer Hofmann-Wellenhof; H Luedtke; Ulf Ellwanger; Anke Steins; S Roehm; Claus Garbe; Hans Peter Soyer
Value of the clinical history for different users of dermoscopy compared with results of digital image analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2004;18(6):665-9.
2004: Matthias Moehrle; Wilfried Schippert; Gernot Rassner; Claus Garbe; Helmut Breuninger
Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2004;30(10):1319-28.
2004: Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Claus Garbe
Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3660-7.
2004: Siegbert Rieg; Claus Garbe; Birgit Sauer; Hubert Kalbacher; Birgit Schittek
Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions.
The British journal of dermatology 2004;151(3):534-9.
2004: Matthias Moehrle; A Kraemer; Wilfried Schippert; Claus Garbe; Gernot Rassner; Helmut Breuninger
Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma.
The British journal of dermatology 2004;151(2):397-406.
2004: Peter Radny; Diana Berner; Thomas K Eigentler; Heinz-Peter Schlemmer; Ulrich M Caroli; Anne Kamin; Claus Garbe
Malignant blue naevus of the scalp.
The lancet oncology 2004;5(7):429.
2004: Ulrike Leiter; Friedegund Meier; Birgit Schittek; Claus Garbe
The natural course of cutaneous melanoma.
Journal of surgical oncology 2004;86(4):172-8.
2004: Jürgen Bauer; Petra Büttner; Heike Luther; Tine Sander Wiecker; Matthias Möhrle; Claus Garbe
Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development.
Archives of dermatology 2004;140(4):493-4.
2004: Hans-Juergen Blaheta; S Roeger; Karl Sotlar; Birgit Schittek; Helmut Breuninger; Burkhard D Bueltmann; Claus Garbe
Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients.
The British journal of dermatology 2004;150(3):477-83.
2004: Claus Garbe; Thomas K Eigentler
[Therapy of malignant melanoma at the stage of distant metastasis].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2004;55(2):195-213.
2004: Peter Radny; Jürgen Bauer; Ulrich M Caroli; Thomas K Eigentler; Anne Kamin; Gisela Metzler; Claus Garbe
Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
Dermatology (Basel, Switzerland) 2004;209(3):249-50.
2004: Matthias Möhrle; Wilfried Schippert; Gernot Rassner; Claus Garbe; Helmut Breuninger
Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
Dermatology (Basel, Switzerland) 2004;209(1):5-13.
2003: Andreas Blum; Hans Peter Soyer; Claus Garbe; H Kerl; Gernot Rassner; Rainer Hofmann-Wellenhof
The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions.
The British journal of dermatology 2003;149(6):1159-64.
2003: Thomas K Eigentler; Ulrich M Caroli; Peter Radny; Claus Garbe
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.
The lancet oncology 2003;4(12):748-59.
2003: Peter Radny; Ulrich M Caroli; Jürgen Bauer; T Paul; C Schlegel; Thomas K Eigentler; Benjamin Weide; M Schwarz; Claus Garbe
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.
British journal of cancer 2003;89(9):1620-6.
2003: Angelika Iftner; Stefanie J Klug; Claus Garbe; Andreas Blum; Alice Stancu; Sharon P Wilczynski; Thomas Iftner
The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Cancer research 2003;63(21):7515-9.
2003: Peter Meyer; Rüdiger Klaes; Christina Schmitt; Melanie Barbara Boettger; Claus Garbe
Exclusion of BRAFV599E as a melanoma susceptibility mutation.
International journal of cancer. Journal international du cancer 2003;106(1):78-80.
2003: Matthias Möhrle; Wilfried Schippert; Claus Garbe; Gernot Rassner; M Röcken; Helmut Breuninger
[Prognostic parameters and surgical strategies for facial melanomas].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2003;1(6):457-63.
2003: Friedegund Meier; Ulrich M Caroli; Kapaettu Satyamoorthy; Birgit Schittek; Jürgen Bauer; Carola Berking; Helga Möller; Evelyn Maczey; Gernot Rassner; Meenhard Herlyn; Claus Garbe
Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma.
Experimental dermatology 2003;12(3):296-306.
2003: Andreas Blum; Dorothea Blum; Waltraud Stroebel; Gernot Rassner; Claus Garbe; Martin Hautzinger
[Psychosocial burden and subjective experience of melanoma patients in the ambulant follow-up].
Psychotherapie, Psychosomatik, medizinische Psychologie 2003;53(6):258-66.
2003: Soheil S Dadras; Thomas Paul; Jennifer Bertoncini; Lawrence F Brown; Alona Muzikansky; David G Jackson; Ulf Ellwanger; Claus Garbe; Martin C Mihm; Michael Detmar
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
The American journal of pathology 2003;162(6):1951-60.
2003: Jürgen Bauer; Claus Garbe
Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2003;16(3):297-306.
2003: Andreas Blum; Gernot Rassner; Claus Garbe
Modified ABC-point list of dermoscopy: A simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions.
Journal of the American Academy of Dermatology 2003;48(5):672-8.
2003: Matthias Moehrle; Silke Metzger; Wilfried Schippert; Claus Garbe; Gernot Rassner; Helmut Breuninger
"Functional" surgery in subungual melanoma.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2003;29(4):366-74.
2003: Claus Garbe; Ulrike Leiter; Ulf Ellwanger; Hans-Juergen Blaheta; Friedegund Meier; Gernot Rassner; Birgit Schittek
Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.
Cancer 2003;97(7):1737-45.
2003: Matthias Moehrle; Bernhard Dennenmoser; Claus Garbe
Continuous long-term monitoring of UV radiation in professional mountain guides reveals extremely high exposure.
International journal of cancer. Journal international du cancer 2003;103(6):775-8.
2003: Claus Garbe; Andrena Paul; Hanna Kohler-Späth; Ulf Ellwanger; Waltraud Stroebel; Monika Schwarz; Bettina Schlagenhauff; Friedegund Meier; Birgit Schittek; Hans-Juergen Blaheta; Andreas Blum; Gernot Rassner
Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):520-9.
2003: Tine Sander Wiecker; Heike Luther; Petra G Buettner; Jürgen Bauer; Claus Garbe
Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children.
Cancer 2003;97(3):628-38.
2002: Jürgen Bauer; Hauke Schumann; Karsten Sönnichsen; Maren Tomaske; Axel Bosk; Leena Bruckner-Tuderman; Gernot Rassner; Claus Garbe
Molecular diagnostics facilitate distinction between lethal and non-lethal subtypes of junctional epidermolysis bullosa: a case report and review of the literature.
European journal of pediatrics 2002;161(12):672-9.
2002: Thomas Flad; Ralf Bogumil; Jonathan Tolson; Birgit Schittek; Claus Garbe; Martin Deeg; Claudia Mueller; Hubert Kalbacher
Detection of dermcidin-derived peptides in sweat by ProteinChip technology.
Journal of immunological methods 2002;270(1):53-62.
2002: Friedegund Meier; S Will; Ulf Ellwanger; Bettina Schlagenhauff; Birgit Schittek; Gernot Rassner; Claus Garbe
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
The British journal of dermatology 2002;147(1):62-70.
2002: Claus Garbe; Ulf Ellwanger; Michael Tronnier; Eva-Bettina Brocker; Constantin E Orfanos
The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
Cancer 2002;94(8):2305-7.
2002: Claus Garbe
A rational approach to the follow-up of melanoma patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;160():205-15.
2001: Birgit Schittek; R Hipfel; Birgit Sauer; Jürgen Bauer; Hubert Kalbacher; Stefan Stevanovic; Markus Schirle; K Schroeder; nikolaus blin; F Meier; Gernot Rassner; Claus Garbe
Dermcidin: a novel human antibiotic peptide secreted by sweat glands.
Nature immunology 2001;2(12):1133-7.
2001: Jürgen Bauer; Gisela Metzler; Gernot Rassner; Claus Garbe; Andreas Blum
Dermatoscopy turns histopathologist's attention to the suspicious area in melanocytic lesions.
Archives of dermatology 2001;137(10):1338-40.
2001: Hans-Juergen Blaheta; T Paul; Karl Sotlar; Evelyn Maczey; Birgit Schittek; Andrena Paul; Matthias Moehrle; Helmut Breuninger; Burkhard D Bueltmann; Gernot Rassner; Claus Garbe
Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
The British journal of dermatology 2001;145(2):195-202.
2001: T Paul; Peter Radny; Stefan Kröber; Andrena Paul; Hans-Juergen Blaheta; Claus Garbe
Intralesional rituximab for cutaneous B-cell lymphoma.
The British journal of dermatology 2001;144(6):1239-43.
2001: Karl S Lang; C C Caroli; A Muhm; Dorothee Wernet; Arnaud Moris; Birgit Schittek; E Knauss-Scherwitz; Stefan Stevanovic; Hans-Georg Rammensee; Claus Garbe
HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
The Journal of investigative dermatology 2001;116(6):891-7.
2001: Hans-Juergen Blaheta; Karl Sotlar; Helmut Breuninger; Burkhard D Bueltmann; Gernot Rassner; Claus Garbe; H P Horny
Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma?
Melanoma research 2001;11(1):57-63.
2001: Jürgen Bauer; Andreas Blum; Karsten Sönnichsen; Gisela Metzler; Gernot Rassner; Claus Garbe
Nodular scabies detected by computed dermatoscopy.
Dermatology (Basel, Switzerland) 2001;203(2):190-1.
2001: Andreas Blum; Gisela Metzler; Jürgen Bauer; Gernot Rassner; Claus Garbe
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris.
Dermatology (Basel, Switzerland) 2001;203(1):50-2.
2001: Hans-Juergen Blaheta; Gisela Metzler; Gernot Rassner; Claus Garbe
Hyperkeratosis lenticularis perstans (Flegel's disease)--lack of response to treatment with tacalcitol and calcipotriol.
Dermatology (Basel, Switzerland) 2001;202(3):255-8.
2001: Hans-Juergen Blaheta; Birgit Schittek; Helmut Breuninger; Claus Garbe
Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():137-46.
2001: Birgit Schittek; Hans-Juergen Blaheta; Ulf Ellwanger; Claus Garbe
Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():93-104.
2000: Matthias Moehrle; M Korn; Claus Garbe
Bacillus subtilis spore film dosimeters in personal dosimetry for occupational solar ultraviolet exposure.
International archives of occupational and environmental health 2000;73(8):575-80.
2000: Bettina Schlagenhauff; Birgit Schittek; Ulf Ellwanger; Waltraud Stroebel; Andreas Blum; M Schwarz; Gernot Rassner; Claus Garbe
Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?
Melanoma research 2000;10(5):451-9.
2000: Benjamin Weide; Birgit Schittek; T Klyscz; K Schüz; M Stark; Gernot Rassner; B Wilske; Claus Garbe
Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction.
The British journal of dermatology 2000;143(4):780-5.
2000: Claus Garbe; G R McLeod; Petra G Buettner
Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.
Cancer 2000;89(6):1269-78.
2000: Helmut Breuninger; Claus Garbe; Gernot Rassner
[Shave excision of melanocytic nevi of the skin: indications, technique, results].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2000;51(8):575-80.
2000: C Kuchelmeister; G Schaumburg-Lever; Claus Garbe
Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
The British journal of dermatology 2000;143(2):275-80.
2000: Claus Garbe; Petra G Buettner
Predictors of the use of sunscreen in dermatological patients in Central Europe.
Preventive medicine 2000;31(2 Pt 1):134-9.
2000: Andreas Blum; Bettina Schlagenhauff; Waltraud Stroebel; Helmut Breuninger; Gernot Rassner; Claus Garbe
Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients.
Cancer 2000;88(11):2534-9.
2000: Bettina Schlagenhauff; Ulf Ellwanger; Helmut Breuninger; Waltraud Stroebel; Gernot Rassner; Claus Garbe
Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma.
Melanoma research 2000;10(2):165-9.
2000: Benjamin Weide; T Walz; Claus Garbe
Is morphoea caused by Borrelia burgdorferi? A review.
The British journal of dermatology 2000;142(4):636-44.
2000: Hans-Juergen Blaheta; Ulf Ellwanger; Birgit Schittek; Karl Sotlar; Evelyn Maczey; Helmut Breuninger; MH Thelen; Burkhard D Bueltmann; Gernot Rassner; Claus Garbe
Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
The Journal of investigative dermatology 2000;114(4):637-42.
2000: R Hipfel; Birgit Schittek; Y Bodingbauer; Claus Garbe
Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization.
British journal of cancer 2000;82(6):1149-57.
2000: G Schaumburg-Lever; I Lever; Birgit Fehrenbacher; H Möller; B Bischof; Edwin Kaiserling; Claus Garbe; Gernot Rassner
Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy.
Journal of cutaneous pathology 2000;27(2):67-75.
2000: Matthias Moehrle; B Dennenmoser; Bettina Schlagenhauff; S Thomma; Claus Garbe
High prevalence of seborrhoeic dermatitis on the face and scalp in mountain guides.
Dermatology (Basel, Switzerland) 2000;201(2):146-7.
2000: Matthias Moehrle; L Heinrich; A Schmid; Claus Garbe
Extreme UV exposure of professional cyclists.
Dermatology (Basel, Switzerland) 2000;201(1):44-5.
2000: Matthias Moehrle; Claus Garbe
Personal UV dosimetry by Bacillus subtilis spore films.
Dermatology (Basel, Switzerland) 2000;200(1):1-5.
2000: Petra G Buettner; Claus Garbe
Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination.
American journal of epidemiology 2000;151(1):72-7.
1999: Andreas Blum; CU Brand; Ulf Ellwanger; Bettina Schlagenhauff; Waltraud Stroebel; Gernot Rassner; Claus Garbe
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment.
The British journal of dermatology 1999;141(5):783-7.
1999: Birgit Schittek; Birgit Sauer; Claus Garbe
Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines.
International journal of cancer. Journal international du cancer 1999;82(4):583-6.
1999: Birgit Schittek; Hans-Juergen Blaheta; G Flörchinger; Birgit Sauer; Claus Garbe
Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction.
The British journal of dermatology 1999;141(1):37-43.
1999: Birgit Schittek; Y Bodingbauer; Ulf Ellwanger; Hans-Juergen Blaheta; Claus Garbe
Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
The British journal of dermatology 1999;141(1):30-6.
1999: Hans-Juergen Blaheta; Birgit Schittek; Helmut Breuninger; Karl Sotlar; Ulf Ellwanger; MH Thelen; Evelyn Maczey; Gernot Rassner; Burkhard D Bueltmann; Claus Garbe
Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
The American journal of surgical pathology 1999;23(7):822-8.
1999: Matthias Moehrle; Claus Garbe
Does mountaineering increase the incidence of cutaneous melanoma? A hypothesis based on cancer registry data.
Dermatology (Basel, Switzerland) 1999;199(3):201-3.
1998: R Hipfel; Claus Garbe; Birgit Schittek
RNA isolation from human skin tissues for colorimetric differential display.
Journal of biochemical and biophysical methods 1998;37(3):131-5.
1998: Hans-Juergen Blaheta; Birgit Schittek; Helmut Breuninger; Evelyn Maczey; Stefan Kroeber; Karl Sotlar; Ulf Ellwanger; MH Thelen; Gernot Rassner; Burkhard D Bültmann; Claus Garbe
Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
International journal of cancer. Journal international du cancer 1998;79(4):318-23.
1998: G Astori; D Lavergne; C Benton; B Höckmayr; K Egawa; Claus Garbe; Ethel-Michele de Villiers
Human papillomaviruses are commonly found in normal skin of immunocompetent hosts.
The Journal of investigative dermatology 1998;110(5):752-5.
1998: Claus Garbe
[World conference on melanoma in Sydney 10-14 June 1997].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1998;49(3):231-6.
1998: CU Brand; Andreas Blum; A Schlegel; G Farin; Claus Garbe
Application of argon plasma coagulation in skin surgery.
Dermatology (Basel, Switzerland) 1998;197(2):152-7.
1997: Bettina Schlagenhauff; Waltraud Stroebel; Ulf Ellwanger; Friedegund Meier; C Zimmermann; Helmut Breuninger; Gernot Rassner; Claus Garbe
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations.
Cancer 1997;80(1):60-5.
1997: CU Brand; Ulf Ellwanger; Waltraud Stroebel; Friedegund Meier; Bettina Schlagenhauff; Gernot Rassner; Claus Garbe
Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.
Cancer 1997;79(12):2345-53.
1997: M Carl; Waltraud Stroebel; Gernot Rassner; Claus Garbe
[The difficulty of ultrasound diagnosis of lymph node metastases of malignant melanoma in protracted tumor growth].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1997;48(4):234-9.
1996: Ralf Husak; Claus Garbe; Constantin E Orfanos
Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance.
Journal of the American Academy of Dermatology 1996;35(6):928-34.
1996: Konstantin Krasagakis; U Hettmannsperger; C Trautmann; Beate Tebbe; Claus Garbe
Persistent scleredema of Buschke in a diabetic: improvement with high-dose penicillin.
The British journal of dermatology 1996;134(3):597-8.
1996: M Owsianowski; Claus Garbe; J Ramaker; Constantin E Orfanos; H Gollnick
[Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1996;47(2):114-23.
1995: Jürgen Eberle; Claus Garbe; N Wang; Constantin E Orfanos
Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1995;8(6):307-13.
1995: Claus Garbe; P Büttner; Ulf Ellwanger; C E Orfanos
[Management of primary malignant melanoma of the skin in German-speaking countries 1983-1993. A study of the Malignant Melanoma Central Register of the German Society of Dermatology].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1995;46(11):762-70.
1995: Konstantin Krasagakis; U Hettmannsperger; Beate Tebbe; Claus Garbe
Cutaneous metastatic angiosarcoma with a lethal outcome, following radiotherapy for a cervical carcinoma.
The British journal of dermatology 1995;133(4):610-4.
1995: Claus Garbe; P Büttner; Ulf Ellwanger; E B Bröcker; Ernst G Jung; C E Orfanos; Gernot Rassner; H H Wolff
[The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1995;46(10):683-92.
1995: E Rieger; H P Soyer; Claus Garbe; P Büttner; R Kofler; J Weiss; U Stocker; S Krüger; M Roser; J Weckbecker
Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.
International journal of cancer. Journal international du cancer 1995;62(4):393-7.
1995: K Eckert; F Garbin; H Rainer Maurer; P Büttner; Claus Garbe; J Czarnecki
Prothymosin alpha 1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro.
International journal of immunopharmacology 1995;17(7):555-61.
1995: P Büttner; Claus Garbe; J Bertz; G Burg; B d'Hoedt; H Drepper; I Guggenmoos-Holzmann; W Lechner; Andrea Lippold; Constantin E Orfanos
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
Cancer 1995;75(10):2499-2506.
1995: Claus Garbe; P Büttner; J Bertz; G Burg; B d'Hoedt; H Drepper; I Guggenmoos-Holzmann; W Lechner; Andrea Lippold; Constantin E Orfanos
Primary cutaneous melanoma. Prognostic classification of anatomic location.
Cancer 1995;75(10):2492-8.
1995: Claus Garbe; P Büttner; J Bertz; G Burg; B d'Hoedt; H Drepper; I Guggenmoos-Holzmann; W Lechner; Andrea Lippold; Constantin E Orfanos
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.
Cancer 1995;75(10):2484-91.
1995: B Hübner; K Eckert; Claus Garbe; H Rainer Maurer
Synergistic interactions between interferon beta and carboplatin on SK-MEL 28 human melanoma cell growth inhibition in vitro.
Journal of cancer research and clinical oncology 1995;121(2):84-8.
1995: Jürgen Eberle; Claus Garbe; Constantin E Orfanos
Identification of genes specifically regulated in human melanoma cells.
Archives of dermatological research 1995;287(5):421-7.
1995: Konstantin Krasagakis; Claus Garbe; Jürgen Eberle; Constantin E Orfanos
Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro.
Archives of dermatological research 1995;287(3-4):259-65.
1995: S Schmitz; Claus Garbe; K Jimbow; A Wulff; H Daniels; Jürgen Eberle; Constantin E Orfanos
Photodynamic action of ultraviolet A: induction of cellular hydroperoxides.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():43-55.
1995: Claus Garbe
Perspectives of cytokine treatment in malignant skin tumors.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():349-69.
1995: Konstantin Krasagakis; Claus Garbe; Christos Zouboulis; Constantin E Orfanos
Growth control of melanoma cells and melanocytes by cytokines.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():169-82.
1995: S Krüger-Krasagakes; Konstantin Krasagakis; Claus Garbe; T Diamantstein
Production of cytokines by human melanoma cells and melanocytes.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():155-68.
1995: Jürgen Eberle; Claus Garbe; G Kroumpouzos; Constantin E Orfanos
Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():123-35.
1995: Constantin E Orfanos; Ralf Husak; U Wölfer; Claus Garbe
Kaposi's sarcoma: a reevaluation.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():275-96.
1994: Konstantin Krasagakis; Claus Garbe; P I Schrier; Constantin E Orfanos
Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Anticancer research 1994;14(6B):2565-71.
1994: F Garbin; K Eckert; P Büttner; Claus Garbe; H Rainer Maurer
Prothymosin alpha augments deficient antitumor activity of monocytes from melanoma patients in vitro.
Anticancer research 1994;14(6B):2405-11.
1994: Claus Garbe; S Drechsler; H Fiedler; W Tilgen; M Landthaler; K Schroeder; K H Kuehne; L Faerber
Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.
Seminars in oncology 1994;21(5 Suppl 9):12-6.
1994: G Kroumpouzos; Jürgen Eberle; Claus Garbe; Constantin E Orfanos
P53 mutation and c-fos overexpression are associated with detection of the antigen VLA-2 in human melanoma cell lines.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1994;7(5):348-53.
1994: Claus Garbe; P Büttner; J Weiss; H P Soyer; U Stocker; S Krüger; M Roser; J Weckbecker; R Panizzon; F Bahmer
Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
The Journal of investigative dermatology 1994;102(5):700-5.
1994: Claus Garbe; P Büttner; J Weiss; H P Soyer; U Stocker; S Krüger; M Roser; J Weckbecker; R Panizzon; F Bahmer
Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
The Journal of investigative dermatology 1994;102(5):695-9.
1993: Konstantin Krasagakis; Claus Garbe; Constantin E Orfanos
Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions--an overview.
Melanoma research 1993;3(6):425-33.
1993: Claus Garbe
Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
Melanoma research 1993;3(4):291-9.
1993: Konstantin Krasagakis; Claus Garbe; S Krüger-Krasagakes; Constantin E Orfanos
12-O-tetradecanoylphorbol-13-acetate not only modulates proliferation rates, but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitro.
The Journal of investigative dermatology 1993;100(5):653-9.
1993: Christos Zouboulis; P Büttner; D Djawari; W Kirch; W Keitel; Claus Garbe; H J von Keyserlingk-Eberius; C E Orfanos
[The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1993;44(2):81-5.
1993: Claus Garbe; Konstantin Krasagakis
Effects of interferons and cytokines on melanoma cells.
The Journal of investigative dermatology 1993;100(2 Suppl):239S-244S.
1993: Claus Garbe; J Weiss; S Krüger; E Garbe; P Büttner; J Bertz; H Hoffmeister; I Guggenmoos-Holzmann; Ernst G Jung; Constantin E Orfanos
The German melanoma registry and environmental risk factors implied.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;128():69-89.
1993: J Weiss; Claus Garbe; P Büttner; Ernst G Jung
Dysplastic nevi-dysplastic nevus syndromes: clinical features and genetic aspects.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;128():101-18.
1992: S Krüger-Krasagakes; Claus Garbe; P Kossman; Constantin E Orfanos
A rapid and sensitive fluorometric microassay for determining cell mediated cytotoxicity to adherent growing cell lines.
Journal of immunological methods 1992;156(1):1-8.
1992: S Krüger; Claus Garbe; P Büttner; R Stadler; I Guggenmoos-Holzmann; Constantin E Orfanos
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Journal of the American Academy of Dermatology 1992;26(6):920-6.
1992: Claus Garbe; Ernst D Kreuser; Christos Zouboulis; R Stadler; Constantin E Orfanos
Combined treatment of metastatic melanoma with interferons and cytotoxic drugs.
Seminars in oncology 1992;19(2 Suppl 4):63-9.
1992: Claus Garbe; Constantin E Orfanos
Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1992;Suppl 2():285-94.
1991: Konstantin Krasagakis; Claus Garbe; S Krüger; Constantin E Orfanos
Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.
The Journal of investigative dermatology 1991;97(2):364-72.
1991: Christos Zouboulis; Claus Garbe; Konstantin Krasagakis; S Krüger; Constantin E Orfanos
A fluorometric rapid microassay to identify anti-proliferative compounds for human melanoma cells in vitro.
Melanoma research 1991;1(2):91-5.
1991: Claus Garbe; Harald Stein; D Dienemann; Constantin E Orfanos
Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases.
Journal of the American Academy of Dermatology 1991;24(4):584-90.
1991: R Stadler; Claus Garbe
Disseminated malignant melanoma. New therapeutic approaches.
International journal of dermatology 1991;30(4):239-42.
1991: Michael Detmar; G Pauli; Ioannis Anagnostopoulos; U Wunderlich; Hermann Herbst; Claus Garbe; Harald Stein; Constantin E Orfanos
A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I.
The British journal of dermatology 1991;124(2):198-202.
1991: Beate Tebbe; A Mayer-da-Silva; Claus Garbe; H J von Keyserlingk; Constantin E Orfanos
Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuing therapy.
International journal of dermatology 1991;30(2):114-20.
1991: Claus Garbe; S Thiess; F Nürnberger; G Ehlers; Gisela Albrecht; F Lindlar; J Bertz
Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
Acta dermato-venereologica 1991;71(6):506-11.
1990: Christos Zouboulis; K Schröder; Claus Garbe; Konstantin Krasagakis; S Krüger; Constantin E Orfanos
Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-alpha on sensitive human melanoma cells in vitro may result in selection of cells with enhanced markers of malignancy.
The Journal of investigative dermatology 1990;95(6 Suppl):223S-230S.
1990: Claus Garbe; Konstantin Krasagakis; Christos Zouboulis; K Schröder; S Krüger; R Stadler; Constantin E Orfanos
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype.
The Journal of investigative dermatology 1990;95(6 Suppl):231S-237S.
1990: J Masenga; Claus Garbe; J Wagner; Constantin E Orfanos
Staphylococcus aureus in atopic dermatitis and in nonatopic dermatitis.
International journal of dermatology 1990;29(8):579-82.
1990: J Weiss; Claus Garbe; J Bertz; H Biltz; G Burg; B Hennes; Ernst G Jung; H W Kreysel; Constantin E Orfanos; D Petzold
[Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1990;41(6):309-13.
1989: Claus Garbe; S Krüger; R Stadler; I Guggenmoos-Holzmann; Constantin E Orfanos
Markers and relative risk in a German population for developing malignant melanoma.
International journal of dermatology 1989;28(8):517-23.
1989: R Stadler; A Mayer-da-Silva; B Bratzke; Claus Garbe; Constantin E Orfanos
Interferons in dermatology.
Journal of the American Academy of Dermatology 1989;20(4):650-6.
1989: Claus Garbe; H Wiebelt; Constantin E Orfanos
Change of epidemiological characteristics of malignant melanoma during the years 1962-1972 and 1983-1986 in the Federal Republic of Germany.
Dermatologica 1989;178(3):131-5.